EyePoint Pharmaceuticals, Inc.

EYPTNASDAQ Global Market·USD·Closed

EYPTNASDAQ·USD·Closed

$12.25

−4.74%

$12.25

−$0.61 (4.74%)

52W Range

29thpctl

Volume

1.34×avg

Mkt Cap

1.03BUSD

P/E

-3.5TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

29thpctl

Volume

1.34×avg

Market Cap

1.03BUSD

P/E Ratio

-3.5TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-6.0% / yr

Operating margin-3700.9%

ROIC-111.4%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage0.0×

Current ratio6.66×